|
SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
|
|
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
|
|
Streamlining TAVI: Delivering the Best Patients Outcomes and Efficient Pathways |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
|
|
TAVI Haemodynamics and Outcomes: Are We Measuring Appropriately? |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
|
|
The 2022 ACC Heart Failure Guidelines: What Do They Mean for Your Practice? |
|
|
Transcatheter Aortic Valve Replacement: An Update in Bicuspid Aortic Valve Disease |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
|
|
Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
|
|
Transcatheter Interventions Online - Complete Higher Risk Indicated Percutaneous Coronary Intervention: CHIP Live Cases |
- 1.00 European Board for Accreditation in Cardiology (EBAC)
|
Facebook
Twitter
LinkedIn
Forward
